126 related articles for article (PubMed ID: 15033661)
1. Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas.
Kim YH; Lee HS; Lee HJ; Hur K; Kim WH; Bang YJ; Kim SJ; Lee KU; Choe KJ; Yang HK
Ann Oncol; 2004 Apr; 15(4):574-80. PubMed ID: 15033661
[TBL] [Abstract][Full Text] [Related]
2. [Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer].
Lu B; Zhou YN; Li Q; Wu ZQ; Zhang ZY; Ji R; Guo QH; Liu W
Ai Zheng; 2009 May; 28(5):538-42. PubMed ID: 19624886
[TBL] [Abstract][Full Text] [Related]
3. A study of Smad4 and Smad7 expression in surgically resected samples of gastric adenocarcinoma and their correlation with clinicopathological parameters and patient survival.
Zizi-Sermpetzoglou A; Myoteri D; Arkoumani E; Voultsos M; Marinis A
J BUON; 2014; 19(1):221-7. PubMed ID: 24659668
[TBL] [Abstract][Full Text] [Related]
4. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
[TBL] [Abstract][Full Text] [Related]
5. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
[TBL] [Abstract][Full Text] [Related]
6. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
7. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
[TBL] [Abstract][Full Text] [Related]
8. Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer.
Leng A; Liu T; He Y; Li Q; Zhang G
Exp Mol Pathol; 2009 Aug; 87(1):48-53. PubMed ID: 19341727
[TBL] [Abstract][Full Text] [Related]
9. Expression of BAMBI and its combination with Smad7 correlates with tumor invasion and poor prognosis in gastric cancer.
Zhang Y; Yu Z; Xiao Q; Sun X; Zhu Z; Zhang J; Xu H; Wei M; Sun M
Tumour Biol; 2014 Jul; 35(7):7047-56. PubMed ID: 24752577
[TBL] [Abstract][Full Text] [Related]
10. [Studies of TGF-beta/Smads expression in lung cancer].
Shen JL; Yan CH; Liu Y; Yan XQ; Zhang XL; Jin Y; Zhang KF; Sang ZF; Zhang GY; Li P; Fu SB
Yi Chuan Xue Bao; 2003 Jul; 30(7):681-6. PubMed ID: 14579540
[TBL] [Abstract][Full Text] [Related]
11. Expression of VEGF-D, SMAD4, and SMAD7 and Their Relationship with Lymphangiogenesis and Prognosis in Colon Cancer.
Su F; Li X; You K; Chen M; Xiao J; Zhang Y; Ma J; Liu B
J Gastrointest Surg; 2016 Dec; 20(12):2074-2082. PubMed ID: 27730400
[TBL] [Abstract][Full Text] [Related]
12. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.
Kuga H; Morisaki T; Nakamura K; Onishi H; Noshiro H; Uchiyama A; Tanaka M; Katano M
Oncogene; 2003 Oct; 22(49):7838-47. PubMed ID: 14586410
[TBL] [Abstract][Full Text] [Related]
14. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.
Denissova NG; Pouponnot C; Long J; He D; Liu F
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6397-402. PubMed ID: 10823886
[TBL] [Abstract][Full Text] [Related]
16. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
17. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
[TBL] [Abstract][Full Text] [Related]
19. Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis.
Nam SY; Lee HS; Jung GA; Choi J; Cho SJ; Kim MK; Kim WH; Lee BL
APMIS; 2003 Dec; 111(12):1105-13. PubMed ID: 14678019
[TBL] [Abstract][Full Text] [Related]
20. Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues.
Matsuo SE; Fiore AP; Siguematu SM; Ebina KN; Friguglietti CU; Ferro MC; Kulcsar MA; Kimura ET
Arq Bras Endocrinol Metabol; 2010 Jun; 54(4):406-12. PubMed ID: 20625653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
